Company Profile of Hangzhou Jinlan Pharm-Drugs Technology Co., Ltd.

Hangzhou Jinlan Pharm-Drugs Technology Co., Ltd. (JL Pharm)  is established in 2012 at the beautiful West Lake – Hangzhou city, China. The company's main business includes R&D, Production and Sales of Formulation, APIs, and intermediates. The company's main products include API, Contrast Media, related formulation, intermediates, and new product development.

Our main business focus on:

• API & Intermediates Research & Supply
• Premix Research & Production
• API & FDF Technical Transfer
• CMO/CDMO/CRO
• Other Raw materials
• FTE (Full Time Employee)
• Pharmaceutical Equipment Advice
• USP/EP/CP/JP Working Standard
• HPLC/GC Columns
• Other Services

Our main products includes:

Sofosbuvir, Velpatasvir, Glecaprevir, Pibrentasvir, Tenofovir disoproxil fumarate, TDF, Tenofovir Alafenamide, Entecavir, Darunavir,

Semaglutide, Tirzepatide, Liraglutide, Retatrutide, Orforglipron, Lixisenatide, Dulaglutide, Insulin Detemir, Insulin Glargine, Insulin Aspart, Insulin Lispro, Insulin Degludec,

Oseltamivir phosphate, Moxifloxacin HCl, Baloxavir Marboxil, Peremivir, Tecovirimat and so on.